Home > Financial Ratios > NURECA

NURECA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for NURECA
Please provide your vote to see the results

NURECA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -112.51-1.79559.746.72108.08

What is the latest Core EBITDA Growth ratio of NURECA ?

The latest Core EBITDA Growth ratio of NURECA is -112.51 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023-112.51
Mar2022-1.79
Mar2021559.74
Mar20206.72
Mar2019108.08

How is Core EBITDA Growth of NURECA Trending?

Years Core EBITDA Growth % Change
Mar2023 -112.51
Negative
Mar2022 -1.79
Negative
Mar2021 559.74
8,229.46
Mar2020 6.72
-93.78
Mar2019 108.08 -

Other Financial Ratios of NURECA


Compare Core EBITDA Growth ratio of peers of NURECA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NURECA ₹288.6 Cr -1.6% 6.9% -15.1% Stock Analytics
POLY MEDICURE ₹15,747.5 Cr 5.4% 3.6% 69.4% Stock Analytics
PREVEST DENPRO ₹492.1 Cr -6.1% 21.7% 25.5% Stock Analytics


NURECA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NURECA

-1.6%

6.9%

-15.1%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses